ALLIANCEBERNSTEIN L.P. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 93 filers reported holding ARCUS BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2024$19,201,710
-11.6%
1,260,782
+9.5%
0.01%
-12.5%
Q1 2024$21,733,297
-4.1%
1,151,128
-2.9%
0.01%
-11.1%
Q4 2023$22,651,530
+35.0%
1,185,944
+26.9%
0.01%
+28.6%
Q3 2023$16,775,765
-20.6%
934,583
-10.2%
0.01%
-22.2%
Q2 2023$21,131,154
+13.8%
1,040,431
+2.2%
0.01%
+12.5%
Q1 2023$18,567,025
+1.4%
1,017,929
+15.0%
0.01%0.0%
Q4 2022$18,304,509
-32.5%
885,131
-14.6%
0.01%
-38.5%
Q3 2022$27,117,000
-5.2%
1,036,597
-8.1%
0.01%0.0%
Q2 2022$28,596,000
-15.3%
1,128,498
+5.5%
0.01%0.0%
Q1 2022$33,767,000
+1783.3%
1,069,943
+2315.2%
0.01%
+1200.0%
Q4 2021$1,793,000
-0.2%
44,300
-14.0%
0.00%0.0%
Q3 2021$1,796,000
+27.0%
51,5000.0%0.00%0.0%
Q2 2021$1,414,000
+11.9%
51,500
+14.4%
0.00%0.0%
Q1 2021$1,264,000
+10.9%
45,000
+2.5%
0.00%0.0%
Q4 2020$1,140,000
+51.6%
43,9000.0%0.00%
Q3 2020$752,000
-39.8%
43,900
-13.1%
0.00%
-100.0%
Q2 2020$1,249,000
+132.6%
50,500
+30.5%
0.00%
Q1 2020$537,000
+73.8%
38,700
+26.5%
0.00%
Q4 2019$309,000
+22.6%
30,600
+10.5%
0.00%
Q3 2019$252,000
+12.0%
27,700
-2.1%
0.00%
Q2 2019$225,000
-17.0%
28,300
+30.4%
0.00%
Q1 2019$271,000
+133.6%
21,700
+100.9%
0.00%
Q4 2018$116,00010,8000.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q1 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,842,077$64,233,00017.21%
Octagon Capital Advisors LP 970,164$33,830,0008.33%
Copernicus Capital Management, LLC 17,000$593,0007.18%
EcoR1 Capital, LLC 5,122,359$178,617,0006.21%
BVF INC/IL 3,229,822$112,624,0004.39%
PFM Health Sciences, LP 3,431,010$119,639,0003.52%
Alphabet Inc. 4,100,475$142,984,0003.39%
Boxer Capital, LLC 2,084,883$72,700,0002.54%
SECTORAL ASSET MANAGEMENT INC 739,010$25,769,0002.14%
Parkman Healthcare Partners LLC 236,637$8,252,0002.09%
View complete list of ARCUS BIOSCIENCES INC shareholders